Wearable Sensors and Video-Based Testing to Track Arm Function After Treatment for Neurogenic Thoracic Outlet Syndrome
Remote Assessment and Digital Biomarker-Based Testing for Neurogenic Thoracic Outlet Syndrome: Longitudinal Follow-up After Physical Therapy or Surgery (Study 2)
The goal of this study is to learn whether wearable motion sensors and video-based movement analysis can track changes in arm function over time in adults with neurogenic thoracic outlet syndrome (NTOS) who are receiving standard treatment (physical therapy or surgery).
NTOS happens when nerves between the neck and shoulder are squeezed, causing pain, numbness, weakness, and trouble using the arm. There is currently no objective test to measure how severe NTOS is or how well treatment is working.
The main questions this study aims to answer are:
- Can digital measurements of arm movement, collected with wearable sensors and with standard webcam video, detect changes in arm function after NTOS treatment?
- Are these digital measurements more sensitive to change than standard questionnaires?
- Do video-based measurements agree with sensor-based measurements?
- Can measurements taken before treatment help predict who will improve with physical therapy?
This study does not assign or change treatment. Physical therapy or surgery is chosen by each participant's doctors as part of usual care.
Participants will:
- Complete 5 study visits over about 12 months: before treatment and 1 and 2 months after treatment (in clinic), and 6 and 12 months after treatment (remote telemedicine visits)
- At each visit, perform a short arm movement task (the "Press Test," a 20-second hand-over-head exercise) while wearing motion sensors and/or being recorded on video
- Complete questionnaires about arm function, pain, mood, and overall health
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Descripción detallada
Neurogenic thoracic outlet syndrome (NTOS) is a disorder of dynamic compression of the brachial plexus between the first rib and the scalene muscles. Diagnosis currently relies on subjective clinical assessment, and there are no objective measures to monitor response to treatment. This study evaluates a remote patient monitoring platform that extracts digital biomarkers of upper extremity motor function from the Press Test, a 20-second repetitive hand-over-head task designed to provoke NTOS symptoms.
This is a single-site, prospective longitudinal study at the UCLA Thoracic Outlet Syndrome Center. Adults with a treating-physician diagnosis of NTOS who are proceeding with standard-of-care treatment (physical therapy and/or surgery) are followed for 12 months. Treatment selection is made by the treating clinicians and is not assigned by the study. Approximately 50 participants undergoing physical therapy and 50 undergoing surgery will be enrolled.
At each of five time points (baseline 0-1 month before treatment; 1, 2, 6, and 12 months after treatment), participants perform the Press Test while digital biomarkers are captured with wearable inertial sensors and with AI-based analysis of standard webcam video. The baseline, 1-month, and 2-month assessments are performed in person; the 6- and 12-month assessments are performed remotely via secure telehealth, with sensors provided in clinic or mailed to the participant with written instructions and staff support. Patient-reported outcomes (DASH, VAS pain, Zung Self-Rating Depression Scale, and PROMIS Global Health) are collected at each time point. Feasibility and acceptability of remote assessment are evaluated through visit completion rates, time burden, technical issues, and a technology acceptance questionnaire.
Analyses will use linear and generalized linear mixed models to assess change over time, intraclass correlation coefficients and Bland-Altman analyses to compare sensor- and video-derived measures, and exploratory models to identify baseline predictors of response to physical therapy.
This study is funded by the National Institutes of Health (R01HD121303).
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Adults aged 18 to 60 years with a treating-physician diagnosis of neurogenic thoracic outlet syndrome who are evaluated at the UCLA Thoracic Outlet Syndrome Center and are proceeding with standard-of-care physical therapy or surgery.
Descripción
Inclusion Criteria:
- Men or women aged 18 to 60 years
- Treating-physician diagnosis of neurogenic thoracic outlet syndrome (NTOS)
- Plan for standard-of-care treatment (physical therapy and/or surgery) at UCLA
- Right-handed, left-handed, or ambidextrous
- Able to provide informed consent and complete study activities
Exclusion Criteria:
- Bilateral NTOS
- Previous surgery for NTOS at any time, or NTOS-directed physical therapy within the past 2 months
- Venous thoracic outlet syndrome
- Arterial thoracic outlet syndrome
- NTOS together with another condition affecting the upper extremity
- Cognitive impairment
- Acute or chronic conditions unrelated to NTOS that may affect upper extremity function (e.g., stroke, Parkinson's disease, arthritis, cancer)
- History of drug or alcohol abuse within the past 6 months
- Inability to participate in follow-up assessments (e.g., plans to move out of state within 12 months, or inability to complete remote follow-up visits)
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Modelos observacionales: COHORT
- Perspectivas temporales: PROSPECTIVE
Número de grupos/cohortes
Cohortes e Intervenciones
Grupo / CohorteGrupo / Cohorte |
|---|
|
Physical Therapy
Adults with neurogenic thoracic outlet syndrome whose treating physician has recommended standard-of-care physical therapy. Participants complete digital biomarker assessments (Press Test with wearable sensors and webcam video) and patient-reported outcome questionnaires before treatment and at 1, 2, 6, and 12 months after treatment. Treatment is not assigned by the study. |
|
Surgery
Adults with neurogenic thoracic outlet syndrome whose treating physician has recommended standard-of-care surgical decompression (e.g., first rib resection, scalenectomy, and brachial plexus neurolysis). Participants complete digital biomarker assessments (Press Test with wearable sensors and webcam video) and patient-reported outcome questionnaires before treatment and at 1, 2, 6, and 12 months after treatment. Treatment is not assigned by the study. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Press Test Digital Biomarkers of Upper Extremity Function
Periodo de tiempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
Digital biomarkers of upper extremity motor function (representing slowness, weakness, rigidity, exhaustion, and unsteadiness, e.g., speed, power, rise time, and range of motion) extracted from a 20-second repetitive hand-over-head Press Test using wearable inertial sensors and AI-based webcam video analysis. Change from baseline will be assessed at each follow-up time point. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
|
Change in Disabilities of the Arm, Shoulder and Hand (DASH) Score
Periodo de tiempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
The DASH is a 30-item self-reported questionnaire of upper extremity disability and symptoms. Scores range from 0 to 100; higher scores indicate greater disability. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Pain Intensity (Visual Analog Scale)
Periodo de tiempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
Self-reported pain intensity on a 0 to 10 visual analog scale; higher scores indicate worse pain. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
|
Change in Zung Self-Rating Depression Scale (SDS) Score
Periodo de tiempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
20-item self-reported depression scale. Raw scores range from 20 to 80; higher scores indicate more severe depressive symptoms. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
|
Change in PROMIS Global Health Physical and Mental Health T-Scores
Periodo de tiempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
PROMIS Global Health v1.2 (10 items) yields Global Physical Health and Global Mental Health T-scores (population mean 50, SD 10); higher scores indicate better health. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
|
Agreement Between Sensor-Based and Video-Based Digital Biomarkers
Periodo de tiempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
Agreement between digital biomarkers derived from wearable sensors and from AI-based webcam video analysis during the Press Test, assessed by intraclass correlation coefficient (ICC) at each time point. |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
|
Baseline Digital Biomarkers as Predictors of Response to Physical Therapy
Periodo de tiempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
Performance of machine learning models using pre-treatment digital biomarkers, demographics, and clinical factors to predict non-response to physical therapy (no meaningful symptom improvement), reported as area under the ROC curve (AUC). |
Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
Otros números de identificación del estudio
- IRB-26-0380-Study2
- R01HD121303 (Subvención/contrato del NIH de EE. UU.)
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .